Oregon Just Priced Out the Psychedelic Program It Built for Everyone Else

Ryan Reid co-founded Bendable Therapy, a psilocybin service center in Bend, Oregon. On June 27, 2026, he learned his annual state licensing costs could jump by as much as $50,000 under a proposal from the Oregon Health Authority. “I don’t think the industry can survive this,” he told The Bulletin.

Oregon built the only legal, regulated psilocybin-services program in the country specifically so supervised access wouldn’t be limited to people who can afford a boutique retreat.

A state agency just proposed a fee schedule that guts the discount built into that program for the exact people it was designed to reach.

Here’s the mechanism, in plain terms: Oregon licenses psilocybin manufacturers, testing labs, service centers, and the facilitators who supervise sessions, and it charges each of them an annual fee to operate. Since the program launched, nonprofit, veteran-owned, and low-income service centers paid a reduced $5,000 fee — a deliberate carve-out meant to keep the door open to operators who weren’t running high-margin wellness businesses. Under the new proposal, that discounted rate would quadruple to $20,000, the same rate charged to for-profit manufacturers, whose own fee is only doubling, from $10,000 to $20,000. Facilitator licenses would double from $2,000 to $4,000, with veteran and low-income discounts eliminated entirely, and work permits — required for anyone working inside a licensed facility — would jump from $25 to $200. Most of the increases would land in 2027; a separate doubling of testing-lab fees is scheduled for 2029.

The math already looks grim. Nearly a third of Oregon’s roughly 400 psilocybin licenses currently qualify for the reduced-fee tier the proposal would erase, and about half of the 39 service center licenses ever issued in the state have already expired or been surrendered. Daniel Huson, director of Rose City Laboratories, said the numbers make testing an unattractive business to be in at all: “There’s no incentive to be a testing laboratory because it’s expensive. And they’re going to be in trouble.” Heidi Pendergast, director of the Healing Advocacy Fund, called the hikes “unprecedented” and out of step with how Oregon licenses cannabis businesses — a comparison that lands, since psilocybin services were pitched to voters as a therapeutic, low-barrier alternative to the wellness-retreat model, not a repeat of it.

Eric Lee, founder of Space Psychedelic Clinic, put the access question bluntly: “There is a vast segment of the population that will just never be able to use legal psychedelics because of the price point.” That’s the real cost of this proposal. It’s not that Oregon’s program disappears — well-capitalized manufacturers and clinics serving wealthier clients will absorb a doubled fee. It’s that the deliberately cheaper on-ramp for nonprofits and veterans quietly closes, and the program drifts toward exactly the retreat-for-the-wealthy model it was created to avoid.

The fee schedule is still a proposal, not a rule, but four-figure line items on a spreadsheet are how policy quietly narrows who gets access to care.